| Drug |
Enzyme/Transporter Implicated |
References |
|
| Antiandrogens |
|
|
| Bicalutamide |
Inhibits CYP3A4 |
Cockshott, 2004 |
| Flutamide |
Metabolized by CYP1A and CYP3A |
Berson et al, 1993;
Shet et al, 1997 |
| |
Inhibits CYP1B1 |
Rochat et al, 2001 |
5 -reductase inhibitors |
|
|
| Dutasteride |
Metabolized by CYP3A4 |
Andriole and Kirby, 2003 |
| Finasteridex |
Metabolized by CYP3A4 |
Huskey et al, 1995 |
| |
Induces GST- |
Montironi et al, 1999 |
-adrenergic antagonists |
|
|
| Doxazosin |
Transported by MDR1 |
Takara et al, 2002 |
| Indoramin |
Metabolized by CYP (unspecified); sulfonation |
Pierce, 1990 |
| Prazosin |
Inhibitor of hOCT1 and hOCT3 |
Hayer-Zillgen et al, 2002 |
| |
Transported by BCRP |
Ozvegy et al, 2001 |
| Tamsulosin |
Metabolized by CYP3A4 and CYP2D6 |
Kamimura et al, 1998 |
| Miscellaneous cytotoxic agents |
|
|
| Cyclophosphamide |
Activation by CYP2Cs |
Chang et al, 1997 |
| |
Metabolized by CYP3A4 |
Huang et al, 2000; Murray et
al, 1994 |
| Dacarbazine |
Activation by CYP1A; CYP2E at higher concentrations |
Long and Dolan, 2001;
Reid et al, 1999 |
| Docetaxel |
Metabolized by CYP3A4 and CYP3A5 |
Cresteil et al, 2002;
Shou et al, 1998 |
| Doxazosin |
Transported by MDR1 |
Takara et al, 2002 |
| Etoposide |
Metabolized by CYP3A4 |
Relling et al, 1994;
Kawashiro et al, 1998 |
| |
Transported by P-gp |
Shapiro and Ling, 1998 |
| Flavopiridol |
Transported by ABCG2 |
Doyle and Ross, 2003 |
| |
Metabolized by UGT1A1, UGT1A9, UGT1A10 |
Hagenauer et al, 2001 |
| Ifosfamide |
Activation by CYP2Cs |
Chang et al, 1997 |
| |
Metabolized by CYP3A4 |
Huang et al, 2000; Murray et
al, 1994 |
| |
Metabolized by CYP2B6 |
Huang et al, 2000 |
| JM216 |
Inhibited CYP2C8 and CYP3A4 |
Ando et al, 1998 |
| Lilopristone |
Metabolized by CYP3A4 |
Jang and Benet, 1997 |
| Methotrexate |
Transported by MRP1-4 |
Chen et al, 2003 |
| |
Transported by ABCG2(BCRP) |
Chen et al, 2003;
Doyle and Ross, 2003 |
| Mifepristone |
Metabolized by CYP3A4 |
Heikinheimo, 1997;
Jang et al, 1996 |
| |
Metabolized by CYP3A4 and CYP3A5 |
Khan et al, 2002 |
| Mitoxantrone |
Transported by ABCG2(BCRP) |
Cooray et al, 2004;
Doyle and Ross, 2003 |
| Navelbine |
Inhibits CYP3A4 |
Zhou et al, 1993 |
| Onapristone |
Metabolized by CYP3A4 |
Jang and Benet, 1997 |
| Paclitaxel |
Metabolized by CYP3A4 and CYP2C8 |
Cresteil et al, 2002 |
| Tamoxifen |
-hydroxylation by CYP3A4 |
Boocock et al, 2002 |
| |
4-hydroxylation by CYP2D6 and CYP2B6 at high substrate concentrations |
Boocock et al, 2002;
Crewe et al, 2002 |
| |
N-demethylation by CYP2D6, CYP1A1, CYP3A4 |
Crewe et al, 2002 |
| |
Trans-cis isomerization by CYP1B1 |
Crewe et al, 2002 |
|